BetterLife Pharma Inc.
BETRF
$0.11
$0.0330.67%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 57.70% | 56.11% | 83.70% | 61.39% | -19.36% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -143.08% | -141.12% | -168.17% | -151.91% | 660.56% |
| Change in Net Operating Assets | 69.97% | 6,051.55% | 463.56% | 217.15% | 111.70% |
| Cash from Operations | 69.04% | 90.50% | 86.29% | 41.30% | 19.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -66.43% | -98.36% | -98.36% | -100.00% | 308.07% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -70.16% | -75.16% | -80.74% | 9.29% | -67.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -100.00% | -100.00% | -- |
| Cash from Financing | -68.46% | -90.67% | -90.70% | -64.54% | -20.89% |
| Foreign Exchange rate Adjustments | -- | 0.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.58% | 85.25% | -252.91% | -332.99% | -197.40% |